<p>John Gill, Director at Altimmune Inc., reported the acquisition of common shares of Altimmune Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001409939-25-000005), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>John Gill, Director at Altimmune Inc., has acquired common shares of the company. This event was reported through a filing accessible via EDGAR, the U.S. SEC's system. The information was published by Altimmune Inc. on December 23, 2025, and is for informational purposes only.</p>

Altimmune Director John Gill Reports Acquisition of Common Shares